GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bavarian Nordic A/S BAVA.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

246.80

+2.41%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in DKK, from our data supplier.

FY2025

Revenue

DKK 6.17bn

FY2016FY2025

Net income

DKK 1.38bn

FY2016FY2025

Free cash flow

DKK 1.36bn

FY2016FY2025

Shareholders' equity

DKK 12.87bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueDKK 6.17bnDKK 5.72bnDKK 7.06bnDKK 3.15bnDKK 1.90bnDKK 1.85bnDKK 662.5mDKK 500.6mDKK 1.37bnDKK 1.01bn
Research and developmentDKK 774.0mDKK 862.5mDKK 2.23bnDKK 1.18bnDKK 399.2mDKK 341.4mDKK 409.3mDKK 386.3mDKK 518.4mDKK 463.2m
Operating incomeDKK 920.8mDKK 985.0mDKK 1.50bn−DKK 3.8m−DKK 351.9mDKK 449.6m−DKK 343.3m−DKK 319.5mDKK 307.6mDKK 67.3m
Net incomeDKK 1.38bnDKK 988.0mDKK 1.48bn−DKK 347.4m−DKK 464.8mDKK 277.5m−DKK 346.8m−DKK 361.9mDKK 181.3mDKK 30.6m
Diluted earnings per share17.5712.5719.23-4.92-7.425.27-8.57-9.034.490.80

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsDKK 14.95bnDKK 14.41bnDKK 14.35bnDKK 12.39bnDKK 12.09bnDKK 8.76bnDKK 7.05bnDKK 3.06bnDKK 3.15bnDKK 2.82bn
Cash and short-term investmentsDKK 3.33bnDKK 2.18bnDKK 1.87bnDKK 2.85bnDKK 3.72bnDKK 1.67bnDKK 472.4mDKK 2.32bnDKK 2.59bnDKK 1.91bn
Total liabilitiesDKK 2.08bnDKK 3.00bnDKK 4.01bnDKK 5.24bnDKK 4.71bnDKK 3.86bnDKK 5.18bnDKK 880.3mDKK 646.4mDKK 806.5m
DebtDKK 56.4mDKK 128.3mDKK 145.3mDKK 1.19bnDKK 4.12bnDKK 3.29bnDKK 4.98bnDKK 646.5mDKK 401.9mDKK 31.9m
Shareholders' equityDKK 12.87bnDKK 11.41bnDKK 10.34bnDKK 7.15bnDKK 7.37bnDKK 4.89bnDKK 1.87bnDKK 2.18bnDKK 2.51bnDKK 2.02bn
Shares outstanding78m79m77m71m63m53m40m40m40m38m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsDKK 2.72bnDKK 1.95bnDKK 1.12bnDKK 220.1m−DKK 358.5mDKK 571.9m−DKK 275.9m−DKK 288.5mDKK 216.1mDKK 267.6m
Capital spending−DKK 1.36bn−DKK 1.69bn−DKK 977.4m−DKK 1.38bn−DKK 1.06bn−DKK 706.7m−DKK 2.67bn−DKK 212.0m−DKK 78.7m−DKK 91.5m
Free cash flowDKK 1.36bnDKK 262.2mDKK 141.8m−DKK 1.16bn−DKK 1.42bn−DKK 134.8m−DKK 2.95bn−DKK 500.5mDKK 137.4mDKK 176.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueDKK 2.03bnDKK 1.06bnDKK 1.41bnDKK 1.79bnDKK 1.65bnDKK 1.35bnDKK 2.09bnDKK 1.36bn
Operating incomeDKK 745.1m−DKK 6.2m−DKK 18.4mDKK 1.15bnDKK 374.9mDKK 258.9mDKK 710.8mDKK 93.6m
Net incomeDKK 731.6mDKK 17.0m−DKK 298.8mDKK 1.09bnDKK 362.6mDKK 218.8mDKK 770.8mDKK 70.5m
Diluted earnings per share9.630.22-3.8213.964.632.799.810.90
Cash from operationsDKK 351.0m−DKK 751.0mDKK 545.0mDKK 1.29bnDKK 1.27bn−DKK 387.0mDKK 955.0m−DKK 71.0m
Capital spending−DKK 21.0m−DKK 32.0m−DKK 99.0m−DKK 47.0m−DKK 803.0m−DKK 367.0m−DKK 630.0m−DKK 398.0m
Free cash flowDKK 330.0m−DKK 783.0mDKK 446.0mDKK 1.25bnDKK 467.0m−DKK 754.0mDKK 325.0m−DKK 469.0m
Total assetsDKK 14.72bnDKK 14.10bnDKK 14.95bnDKK 15.16bnDKK 13.91bnDKK 13.55bnDKK 14.41bnDKK 13.95bn
Cash and short-term investmentsDKK 2.36bnDKK 2.29bnDKK 3.33bnDKK 2.98bnDKK 1.66bnDKK 1.24bnDKK 2.18bnDKK 1.87bn
DebtDKK 45.9mDKK 56.2mDKK 54.3mDKK 54.3mDKK 54.1mDKK 52.5mDKK 54.6mDKK 51.4m
Shareholders' equityDKK 13.22bnDKK 12.69bnDKK 12.87bnDKK 13.16bnDKK 12.05bnDKK 11.56bnDKK 11.41bnDKK 10.69bn

Financial ratios

Data as of 30 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin14.9%17.2%21.2%-0.1%-18.5%24.3%
Net margin22.3%17.3%20.9%-11.0%-24.5%15.0%
Return on equity10.7%8.7%14.3%-4.9%-6.3%5.7%
Return on assets9.2%6.9%10.3%-2.8%-3.8%3.2%
Free cash flow yield23.8%21.2%12.5%10.4%5.1%11.1%
Revenue growth8.0%-19.1%124.1%66.0%2.5%179.6%
Earnings growth39.2%-33.0%-524.7%-25.3%-267.5%-180.0%
Current ratio4.22x2.07x1.94x1.96x2.49x2.50x
Debt to equity0.00x0.00x0.01x0.24x0.15x0.09x
Equity ratio86.1%79.2%72.0%57.7%61.0%55.9%
Interest coverage70.08x71.34x14.19x-0.03x-2.31x2.54x
R&D as a share of sales12.5%15.1%31.5%37.5%21.0%18.4%
Buybacks as a share of market value0.4%-2.4%-8.7%-12.6%-18.9%-30.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue25.1%27.2%19.7%
Operating income—15.4%27.1%
Net income—37.7%36.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin16.0%15.4%13.5%10.8%
Net margin19.9%15.8%12.8%9.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings10.915.19.2-43.3-36.235.5-20.0-14.149.9119.3
Price to sales2.42.61.94.88.95.310.510.26.63.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.